On Friday, Truist Securities reaffirmed its Buy rating on Sutro Biopharma (NASDAQ: NASDAQ:STRO) shares but removed the price target previously set for the company. The decision followed Sutro ...

Sutro Biopharma (NASDAQ:STRO) fell ~14% in the premarket on Friday after the company announced its decision to deprioritize its studies into the antibody-drug conjugate luveltamab tazevibulin as ...

Sutro Bio­phar­ma is re­duc­ing its head­count by 50%, ap­point­ing a new CEO, shut­ting down its on­ly fac­to­ry, and shift­ing away from its lead can­di­date. … ...

The Company will continue to explore global out-licensing opportunities for luvelta, as Sutro still believes in its potential to provide significant benefit to patients with unmet need. Further, given ...

Piper Sandler downgraded Sutro Biopharma (STRO) to Neutral from Overweight with a price target of $2, down from $8. The company is deprioritizing development of luvelta in order to focus resources ...

BofA analyst Tazeen Ahmad downgraded Sutro Biopharma (STRO) to Underperform from Buy with a price target of $1, down from $11. Published first on TheFly – the ultimate source for real-time ...

SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug ...

Sutro’s stock tumbled nearly 19% after the company announced it will sideline its FRα-targeted antibody-drug conjugate luveltamab tazevibulin, which it was studying for ovarian cancer. The biotech ...

It is becoming increasingly likely that more than £46m of debts will be left unpaid after the collapse of the building arm of Devon construction giant Midas. A new report from administrators for ...

Sutro Biopharma (Nasdaq: STRO), a US biotechnology company, has announced significant organizational changes, including a workforce reduction of nearly 50%, a shift in its drug development focus, and ...

– Sutro announced a strategic portfolio review resulting in prioritization of wholly-owned next-generation ADC programs; Key management changes announced as part of transition – – Cash, cash ...